Примери за използване на Foreign particulate matter на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Do not use thesolution if discoloured or if the solution contains foreign particulate matter.
Do not use TRISENOX if you notice foreign particulate matter or if discolouration is present.
The DTPw-HBV component should be well shaken in order toobtain a homogeneous turbid white suspension and should be inspected visually for any foreign particulate matter and/or abnormal physical appearance.
In the event of any foreign particulate matter and/or variation of physical aspect being observed, discard the vial.
The reconstituted solution should be inspected visually for any foreign particulate matter and/or discolouration.
In the event of any foreign particulate matter and/or variation of physical aspect being observed, discard the pre-filled syringe.
Do not use if the solutions are discoloured orif there is other foreign particulate matter in the solutions.
If deviations from this description and/or any foreign particulate matter are observed(including rubber particles from the stopper), the vaccine should be discarded.
The vaccine suspension should be inspected visually before and after reconstitution for any foreign particulate matter and/or abnormal physical appearance.
The solution should be inspected visually for any foreign particulate matter and/or discolouration or any variation in physical appearance prior to administration.
The vaccine should be well shaken in order to obtain a homogeneous turbid white suspension andbe inspected visually for any foreign particulate matter and/or variation of physical aspect.
The vial should be inspected visually for any foreign particulate matter and/or abnormal physical appearance.
Vials containing non-diluted ibalizumab or infusion bag containing diluted ibalizumab must be discarded if solution is cloudy,if there is pronounced discoloration or if there is foreign particulate matter.
This medicine must not be used if you notice foreign particulate matter or if the solution is discoloured.
Before extemporaneous mix, the two vials(antigen and adjuvant) should be allowed to reach room temperature and must be gently swirled between hands andinspected visually for any foreign particulate matter and/or abnormal physical appearance.
The reconstituted vaccine should be inspected visually for any foreign particulate matter and/ or variation of physical aspect prior to administration.
Before mixing the two components, the emulsion(adjuvant) and suspension(antigen) should be brought to room temperature(allow a minimum of 15 minutes); each vial should be shaken andinspected visually for any foreign particulate matter and/or abnormal physical appearance.
The reconstituted vaccine should be inspected visually for any foreign particulate matter and/or abnormal physical appearance prior to administration.
Once the patient is prepared for infusion and the APPROVED Final Product Disposition Notification form has been received, the Provenge bag should be removed from the insulated container and inspected for leaks,external damage, foreign particulate matter, or clumps/clots.
The powder and suspension should be inspected visually for any foreign particulate matter and/or variation of appearance.
The diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliomyelitis(DTPa-HBV-IPV)suspension should be inspected visually for any foreign particulate matter and/or variation of physical aspect.
Do not use thesolution if discoloured or if the solution contains foreign particulate matter(see section 3 for a description of the solution).
Before mixing the two components, the emulsion and suspension should be allowed to reach room temperature, shaken andinspected visually for any foreign particulate matter and/or abnormal physical appearance.
The solvent and reconstituted vaccine should be inspected visually for any foreign particulate matter and/or variation of physical aspects prior to administration.
The vaccine should be visually inspected both before and after re-suspension for any foreign particulate matter and/or change in physical appearance.
The DTPa-HBV-IPV suspension should be inspected visually for any foreign particulate matter and/or variation of physical aspect.
Do not use“product name(to be completed nationally)” if you notice any foreign particulate matter and/or abnormal physical appearance.
The vaccine should be inspected visually prior to administration for any foreign particulate matter and/or abnormal physical appearance.
The vial should be shaken prior to each administration andinspected visually for any foreign particulate matter and/or abnormal physical appearance.
The DTPa-HBV-IPV suspension should be inspected visually for any foreign particulate matter and/ or abnormal physical appearance.